Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Phase 4, open-label, two-year, prospective, multi-center, follow-up study conducted at up 15
sites in USA. Approximately 1,000 patients with moderate-to-severe CKD will be enrolled and
followed for up to 24 months.